Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Francisco Ujueta, M.D.

Concepts (108)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Chelation Therapy102024771.950 Why?
Edetic Acid820242781.370 Why?
Peripheral Arterial Disease4202112990.990 Why?
Cadmium620242160.930 Why?
Chelating Agents820243850.730 Why?
Manganese120233940.720 Why?
Diabetic Angiopathies120198060.450 Why?
Myocardial Infarction72024115150.370 Why?
Myocardial Ischemia2202321390.360 Why?
Venous Thromboembolism1202318840.350 Why?
Metals320227130.300 Why?
Cardiovascular Diseases72024156380.290 Why?
Coronary Artery Bypass1201721940.290 Why?
Environmental Pollutants3202212900.290 Why?
Coronary Angiography1201845260.270 Why?
Diabetes Mellitus3202458870.250 Why?
American Heart Association3202410490.240 Why?
Lead420248800.230 Why?
Radial Artery120241880.210 Why?
Ventricular Premature Complexes120241120.210 Why?
Bundle-Branch Block120242780.200 Why?
Minerals120232820.200 Why?
Catheterization, Peripheral120243460.180 Why?
Embolism120244010.180 Why?
Angina, Unstable120248930.170 Why?
Arsenic120233620.170 Why?
Coronary Artery Disease1201865510.160 Why?
Cardiac Resynchronization Therapy120245590.150 Why?
Incidence42024215520.130 Why?
DiGeorge Syndrome120181870.130 Why?
Meiosis120183270.130 Why?
Postoperative Complications12018158800.130 Why?
Risk Factors82024749150.130 Why?
Vascular Diseases1202411620.120 Why?
Vitamins1202316380.120 Why?
Double-Blind Method42024124500.120 Why?
Placebos1201916680.120 Why?
Lower Extremity1202112140.110 Why?
Diabetes Complications1202013220.110 Why?
Calcinosis1202114850.100 Why?
Meta-Analysis as Topic1201713640.100 Why?
Treatment Outcome82024654090.090 Why?
Ventricular Function, Left1202439410.090 Why?
Humans2420247684510.090 Why?
Pulmonary Embolism1202425910.090 Why?
Aortic Valve1202119680.090 Why?
Dietary Supplements1202334450.090 Why?
Aged1020241715200.080 Why?
Chromosome Mapping1201846220.080 Why?
Environmental Exposure2202345330.080 Why?
Severity of Illness Index22018159650.080 Why?
Drug Therapy, Combination1201963200.080 Why?
Comorbidity12023106010.080 Why?
Atherosclerosis2202134310.080 Why?
Aortic Valve Stenosis1202120320.080 Why?
Randomized Controlled Trials as Topic32024103580.070 Why?
Mortality1201929170.070 Why?
Hypoglycemic Agents1202031110.070 Why?
Alleles1201868900.070 Why?
Risk1201896420.070 Why?
Male1220243647810.060 Why?
Diet1202380980.060 Why?
Female1120243969430.060 Why?
Bundle of His120241020.060 Why?
Middle Aged820242234180.060 Why?
Iliac Vein12024700.060 Why?
Punctures120243720.050 Why?
Stroke1202497910.050 Why?
Research Design1201762170.050 Why?
Heart Failure12024118570.040 Why?
Infusions, Intravenous1202422280.040 Why?
Secondary Prevention1202414790.040 Why?
Risk Assessment32024243110.040 Why?
Cyclin-Dependent Kinase Inhibitor p16120217120.040 Why?
Cross-Sectional Studies12018263510.030 Why?
Chromosomes, Human, Pair 22120183480.030 Why?
Retrospective Studies32024818340.030 Why?
Follow-Up Studies12018394300.030 Why?
Action Potentials1202418370.030 Why?
Angina Pectoris120209600.030 Why?
Diagnostic Tests, Routine120217920.030 Why?
Thrombolytic Therapy1202420580.030 Why?
United States42024731210.030 Why?
Disease Susceptibility1202117970.030 Why?
Recovery of Function1202429940.030 Why?
Acute Disease1202472460.030 Why?
Chromosome Deletion1201813900.030 Why?
Hemorrhage1202434580.030 Why?
Patient Selection1202442660.030 Why?
Heart Rate1202442180.030 Why?
Stents1202432040.020 Why?
Heart Ventricles1202438390.020 Why?
Quality of Life22024134970.020 Why?
Disease Management1202125330.020 Why?
Endovascular Procedures1202422580.020 Why?
Stroke Volume1202456200.020 Why?
Combined Modality Therapy1202185590.020 Why?
Anticoagulants1202448400.020 Why?
Socioeconomic Factors1202178630.020 Why?
Immunohistochemistry12021111380.020 Why?
Survival Rate12021128750.020 Why?
Mass Screening1202154550.020 Why?
Hospitalization12024108450.010 Why?
Prevalence12021158800.010 Why?
Time Factors12024402710.010 Why?
Prognosis12021300280.010 Why?
Prospective Studies12022549140.010 Why?
Adult120222235420.000 Why?
Ujueta's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (108)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.